Conference: 19^th Annual International Conference of the Metabolomics Society

Date: 18–22 June 2023

Place: Niagara Falls Convention Centre, 6815 Stanley Avenue, Niagara Falls, Ontario, Canada L2G 3Y9

Booth: #T12

MDPI will be attending the 19^th Annual International Conference of the Metabolomics Society, which will be held from 18 to 22 June 2023 in downtown Niagara Falls, Canada, at the Niagara Falls Convention Centre.

The conference is the official annual meeting of the Metabolomics Society, and the largest metabolomics meeting worldwide. It will cover the major scientific themes of: technology advances; computational metabolomics, statistics, and bioinformatics; metabolomics in health and disease; and metabolomics of plants, food, environment and microbes. A special theme for this conference will focus on mental health, drug addiction and medicinal cannabis. The scientific program will include plenary and keynote talks, three parallel scientific sessions, interactive poster sessions, sponsor lunches, other networking events and a specially organized parallel session to promote metabolomics research in industry. A strong line-up of both introductory and advanced workshops will take place on Sunday, 18 June, and the morning of Monday, 19 June. To complement the exciting scientific program, the conference will offer a welcome reception, vibrant early career events, a conference dinner and other engaging social activities.

The following MDPI journals will be represented:

• Metabolites;
• Agronomy;
• Antioxidants;
• Applied Biosciences;
• BioMed;
• BioMedInformatics;
• Biomolecules;
• Cancers;
• Cells;
• Children;
• CIMB;
• Diseases;
• Foods;
• Genes;
• JPM;
• Nutrients;
• Plants.

Please do not hesitate to reach out (metabolites@mdpi.com) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

For more information about the conference, please visit the following website: https://www.metabolomics2023.org/.

FEMS was established in 1974 and is now an active and diverse federation of 55 European learned societies that includes around 30,000 professionals who are committed to advancing microbiology for the benefit of society. Located in 38 European countries, around half of these professionals are early career researchers, and the remainder include industry scientists, established academics, educators and campaigners. The 10th FEMS Congress of European Microbiologists will take place in Hamburg, Germany, from 9 to 13 July 2023. This event is dedicated to showcasing the latest developments in microbiology and to connecting microbiologists from all over the world.

Main topics:

• Environmental Microbiology & Ecology;
• Biotechnology & Synthetic Microbiology; 
• Food Microbiology; 
• Infection Biology & Pathogens; 
• Infectious Diseases; 
• Taxonomy & Systematics;
• Genetics & Genomics;
• Virology;
• Microbiology Education & Profession;
• Molecular Microbiology & Biochemistry.

The following MDPI journals will be represented:

• Microorganisms;
• Veterinary Sciences;
• Foods;
• MPs;
• CIMB;
• Diversity;
• Biology;
• Fermentation;
• Microbiology Research;
• JoF;
• Pathogens;
• Antibiotics;
• Biomolecules.

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you at booth #B18 in person and answering any questions you may have. For more information about the conference and our virtual booth, please visit the following link: https://www.fems2023.org/.

Interviewer: Dr. Stephen B. Shears, Inositol Signaling Group, Signal Transduction Laboratory, National Institute of Environmental, Health Sciences, Research Triangle Park, NC, 27709 USA

I am delighted to have been given the opportunity to interview Prof. Dr. Lucio Cocco for the Special Issue of Biomolecules, “Versatility of a Cellular Signaling Scaffold: The Inositol Ring Rules! – Honorary Special Issue Commemorating the Work of Prof. Lucio I. M. Cocco”, that honors his seminal work, which began in the late 1970s with his identification of nuclear phospholipids. During the following decade, Lucio pursued a new concept that, within the nuclear matrix, there are pools of inositol lipids with distinct cell-signaling activities. As noted elsewhere [1], this hypothesis was initially greeted with some skepticism; at that time, the inositol lipid field was preoccupied with the canonical functions of these signaling molecules at the plasma membrane. But Lucio persisted. He and his colleagues subsequently published a considerable and highly influential body of work that has furthered the understanding of the role of this nuclear signaling pathway during myogenic differentiation, giving new insight into its role in myotonic dystrophies, as well as during haemopoietic differentiation, and envisaging the pathophysiological significance of nuclear phosphoinositide signaling in myelodysplastic syndromes.

Dr. Stephen B. Shears (SBS): Hi, Lucio, thanks for agreeing to this interview. Can I begin by asking you to describe the career path that introduced you to phospholipid research?

Prof. Dr. Lucio Cocco (LC): In the mid-1970s I was an undergraduate at the University of Chieti Medical School. As part of my studies in medicine and surgery, Antonio Manzoli became my mentor in the Histology Laboratory. Others [2] had published studies stating that the phospholipid content of active chromatin was 5-fold higher compared to repressed chromatin. We were interested in pursuing the biological significance of this observation with regard to cell cycle regulation, but the stumbling block was the persisting controversy over the extent to which these phospholipids might arise by contamination from non-nuclear membranes. Antonio and I investigated this problem, and we concluded that non-contaminating phospholipids were genuinely associated with non-histone chromosomal proteins (NCHP), perhaps regulating DNA stability and replication. We also reported that NHCP fractions prepared from leukemic B-lymphocytes contained 40% less sphingomyelin and 4-fold higher levels of phosphatidylcholine compared to normal B-cells [3]. This work is also the origin of my interest in cancer research.

SBS: And after you graduated?

LC: I remained at Chieti and studied for a Ph.D. in sports medicine. It seemed such a qualification might provide good employment prospects. I must confess I was also tempted by the possibility of sharing time with famous football players: one of my friends was Leonardo Vecchiet, a university physician who worked with Fino Fini. They were the doctors for the Italian National Football Team, and Fini was also the Director of the Specialty in Sports Medicine.

But my passion for studying the biochemistry and functionality of nuclear lipids prevailed, and in 1978 I accepted a tenured position at the University of Bologna.

SBS: This was a significant change in your academic lifestyle; you swapped an institution that had not yet reached its 20^th birthday for a position at the oldest university in the Western world.

LC: Bologna was a very attractive opportunity; to live in a medieval city that is so rich in history, science and culture, and yet is compact and walkable, in no small part due to its 38 kilometers of porticoes, which were recently added to the UNESCO World Heritage List. It is a wonderful walk to and from the laboratory.

SBS: But almost immediately you took off to Glasgow, Scotland.

LC: In 1979 I began a series of sabbaticals at the Beatson Institute for Cancer Research. The late John Paul was Director at the time. Under his leadership, a small research team, originally housed in the one-time servant’s quarters of a local cancer hospital, had been transformed into a newly constructed, purpose-built institute within the picturesque grounds of Glasgow University; it had attracted several internationally reputed scientific teams and was considered the top place to study gene regulation.

SBS: Our paths almost crossed in the late 1970s; I worked just 74 km from you, at the Edinburgh Medical School. I found it challenging to follow the Edinburgh version of the Scottish accent, but Glaswegian can be incomprehensible.

LC: I had assumed I would be better prepared. English is my second language, courtesy of my father having placed me in an English primary school. However, my wife Erminia and I both struggled at first. Nevertheless, eventually we successfully adapted to this new way of communicating.

SBS: Stewart Gilmour was your colleague at the Beatson; how did he come to share your enthusiasm for nuclear phospholipids?

LC: Stewart and John Paul were studying the regulation of beta-globin genes. I recall a meeting in which I convinced them it could be instructive to investigate if there could be a role for nuclear phospholipids. In 1980, Stewart and I published our first paper together, which described the analysis of Triton-treated nuclear material to remove nuclear membranes [4]. We felt this short paper presented an important finding that put to bed the criticism that phospholipids in our nuclear preparations must have arisen from contaminating membranes: now we had shown nuclear phospholipids need not even be associated with membranes.

SBS: After your return to Bologna in 1983, what specifically drew your attention to the inositol lipids?

LC: The emergence of inositol lipids as cellular signals [5] initially escaped my attention. After all, they are present at very low levels and at that time were canonical plasma membrane signals. However, my enthusiasm for these particular phospholipids changed following the description by Smith and Wells in 1983 [6] of nuclear inositol lipid synthesis.

SBS: And you returned to the UK to pursue this…

LC: In 1985, I visited Stewart, who had relocated to the Institute of Animal Physiology in Babraham, Cambridge, and through him I met Robin Irvine. I asked Robin if we could work together to study nuclear inositol lipids. That was despite us both having our doubts; Smith and Wells had concluded inositol lipid synthesis occurred in the nuclear envelope, which we both thought was probably contaminated by the endoplasmic reticulum. Our hesitancy evaporated when we used 0.4% Triton to prepare membrane-free nuclei that were able to synthesize PtdIns(4,5)P₂ in a cytoplasm-independent manner; this work was published in 1987 [7].

SBS: From looking at your resume, it seems this period was a very busy time: you were Chair of the Anatomy Department at the University of Chieti, and then you became the Director of their post-graduate School in Hygiene.

LC: It was a very interesting time. I took on a number of academic commitments while still remaining active in research, part of which was still going on in Bologna. During this time Stewart and I co-authored several follow-up papers that helped our ideas become more generally accepted, and then others also began to publish studies into nuclear phosphoinositide signaling [8,9].

I would also like to acknowledge Stewart’s continuing guidance as I performed more experiments with Alberto M. Martelli in our Bologna laboratory; we had identified a nuclear-specific species of Phospholipase PLCβ that was activated within 2 minutes’ treatment of 3T3 mouse fibroblasts with insulin-like growth factor-1. These data yielded a manuscript that we submitted to Nature in 1992. The reviewers were positive but demanded additional experiments. Alberto didn't think these were necessary, but I did. However, the journal office put us under pressure to return the manuscript promptly. It was the Easter weekend, which in Italy is the second most important holiday after Christmas. I remember spending Good Friday and Easter Eve in the lab making dozens of Western blots; we were all relieved and excited when the work was accepted for publication in early April of 1992 [10].

SBS: Were there any immediate benefits from the Nature publication?

LC: Naturally, all of the members of our lab were excited by the novelty of the observations, and by the recognition that we were performing research that was deemed to be important to the scientific world. The publication of this work in a journal as prestigious as Nature gave me visibility and subsequently the opportunity to successfully request that our Cellular Signaling Laboratory be set up in Bologna. The location of the laboratory has historical significance in that the space was once occupied by Professor Oliviero Mario Olivo, a distinguished embryologist and labmate of Nobel Laureate Rita Levi Montalcini at the renowned School of Giuseppe Levi in Turin.

Our new setup encouraged generous financial support from the Italian Ministry for Research. Sadly, fundraising in my country is now very difficult; support from private institutions has become very important.

SBS: Another of your important scientific contributions in Bologna has been to organize annual symposia, Advances in Biological Regulation.

LC: This symposium series—originally Advances in Enzyme Regulation—was founded in the United States in the 1960s by George Weber and Sir Hans Krebs. I gave my first presentation in 1978 on the possible role of phospholipids in the nucleus in normal and neoplastic cells [11]. Beginning in 1995, I collaborated with George in the organization of these symposia in Indianapolis. Then, in 2005, George asked me if I felt like continuing his work, and so the symposium was renamed and moved to Bologna.

My feeling is that the success of this so-called closed conference is to bring together a group of scientists that are obliged for two days to communicate with each other, exchange ideas and hopefully initiate new collaborations. I have also been honored that a number of Nobel Laureates accepted my invitations to present plenary lectures. They seemed to have enjoyed the experience, always warmly thanking me for having had the opportunity to participate in this "historic" symposium.

SBS: I would like to express my gratitude for the privilege to attend several of these meetings. I must also thank your lab staff that perform much organizational work behind the scenes, but my special thanks go to Erminia, who is the most generous and gracious hostess each time we have been invited to your apartment in downtown Bologna. I can also testify that an evening stroll through the porticoes is fun too!

I won’t forget one year when attendees were also invited to the anatomical wax museum in Bologna; fortunately, its visitors are no longer treated to a public dissection of freshly executed criminals! I recently learned of this 16^th-century practice from reading your 2000 account of the history of this museum [12].

LC: I was involved in writing this article because as a doctor I had acquired a deep knowledge of anatomy, which is also one of the fundamental disciplines of our department. It was instructive to go back in history and discover that research activities in the eighteenth century took place not in the University but at the Academy of Sciences of the Bologna Institute.

SBS: Another collateral benefit of my attending your Bologna meetings has been to keep me informed of the significant body of work that you have published on the links between nuclear inositol lipid signaling and myelodysplastic syndromes.

LC: In this area of work, Matilde Follo’s paper in the Journal of Clinical Oncology [13] has been particularly important. She and her co-workers determined that mono-allelic deletion of PLCβ1 is associated with worse clinical outcomes in myelodysplastic syndromes. This study captured the attention of hematologists, while also paving the way for further epigenetic analysis that demonstrated how PLCβ1 mRNA levels are predictive of whether the response to azacitidine therapy will be either clinically favorable or lead to a worsening condition; this work was published in PNAS and the Journal of Leukocyte Biology [14,15].

SBS: Recent years have seen considerable documentation of the extent to which women continue to be under-represented in senior scientific positions. Any who might not appreciate your efforts to counter this bias will find it instructive to direct their attention to the list of authors on the publications that you just mentioned.

LC: Throughout my career, I have simply tried to recruit the best scientists. It just worked out that many of these were female. The reward for me has been to mentor a number of female scientists who have attained important and successful academic positions.

SBS: Your most recent publications confirm that you continue to explore new areas of phosphoinositide pathogenesis.

LC: In addition to hematological diseases, my current work is focused on the possible role of abnormalities of PLCs in the pathogenesis of glioblastoma: it is the most common and most malignant of adult gliomas, and hence it also carries the worst prognosis. The first data are very encouraging [16].

SBS: As I reflect upon our brief conversation, I am led to guess you must be deeply satisfied that your early championing of the importance of nuclear inositol lipids has been rewarded with a wealth of data describing their regulation of chromatin remodeling, DNA repair, RNA processing, and gene transcription. Nevertheless, I find it intriguing that recent reviews by you and your colleagues (e.g., [17]) pose some of the same fundamental questions about inositol lipids that you were asking 40 years ago; for example, concerning their origins (nuclear delivery vs. nuclear synthesis?), their biophysical presentation (protein bound and/or present in biomolecular condensates?), and, of course, their mechanisms of action.

LC: We know so much more than we knew in the 1980s, yet full understanding is yet to be achieved. I believe that the most important thing we should solve is the total comprehension of how inositol lipids and other signal transduction systems are responsible for cell growth and differentiation processes. It is the pursuit of this information and the hope of providing new weapons for medical therapy that keeps me inspired and enthusiastic.

SBS: Many of my scientific publications owe much to the collegiate nature of our field and the generosity of my many colleagues. Are there any that were particular sources of inspiration that you would like to acknowledge?

LC: Among the colleagues who have inspired me in the continuation of my research activity, I wish to make particular mention of Robin Irvine, Daniel Raben, John York, Vytas Bankaitis, and last but not least, Sue Goo Rhee and Pann-Ghill Suh, who shared with me their own antibodies against PLCs, which are far superior to any of the commercial ones. I am keen to thank the organizations that have supported me financially in my research: the Italian Ministry of Research, the Italian Association for Cancer Research, the CARISBO Foundation, the Intesa San Paolo Foundation, and the Italian National Research Council.

But the biggest thanks go to my wife Erminia, who has totally supported me since the early years of my career, who followed me to Glasgow and who continues to be a precious stone in the social part of the Advances in Biological Regulation Symposia.

SBS: Thank you very much, Lucio! 

Acknowledgment: This interview was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences, USA. 

References

1. Irvine, R. Nuclear lipid signaling. Sci STKE 2000, 2000, re1, doi:10.1126/stke.2000.48.re1.
2. Rose, H. G.; Frenster, J. H. Composition and metabolism of lipids within repressed and active chromatin of interphase lymphocytes. Biochim Biophys Acta 1965, 106, 577-591, doi:10.1016/0005-2760(65)90073-1.
3. Manzoli, F. A.; Maraldi, N. M.; Cocco, L.; Capitani, S.; Facchini, A. Chromatin phospholipids in normal and chronic lymphocytic leukemia lymphocytes. Cancer Res 1977, 37, 843-849.
4. Cocco, L.; Maraldi, N. M.; Manzoli, F. A.; Gilmour, R. S.; Lang, A. Phospholipid interactions in rat liver nuclear matrix. Biochem Biophys Res Commun 1980, 96, 890-898, doi:10.1016/0006-291x(80)91439-4.
5. Michell, R. H.; Kirk, C. J.; Jones, L. M.; Downes, C. P.; Creba, J. A. The stimulation of inositol lipid metabolism that accompanies calcium mobilization in stimulated cells: defined characteristics and unanswered questions. Philos. Trans. R. Soc. Lond. [Biol] 1981, 296, 123-138.
6. Smith, C. D.; Wells, W. W. Phosphorylation of rat liver nuclear envelopes. II. Characterization of in vitro lipid phosphorylation. J Biol Chem 1983, 258, 9368-9373.
7. Cocco, L.; Martelli, A. M.; Gilmour, R. S.; Ognibene, A.; Manzoli, F. A.; Irvine, R. F. Rapid changes in phospholipid metabolism in the nuclei of Swiss 3T3 cells induced by treatment of the cells with insulin-like growth factor I. Biochem. Biophys. Res. Commun 1988, 154, 1266-1272.
8. Divecha, N.; Banfic, H.; Irvine, R. F. The polyphosphoinositide cycle exists in the nuclei of Swiss 3T3 cells under the control of a receptor (for IGF-I) in the plasma membrane, and stimulation of the cycle increases nuclear diacylglycerol and apparently induces translocation of protein kinase C to the nucleus. EMBO J 1991, 10, 3207-3214, doi:10.1002/j.1460-2075.1991.tb04883.x.
9. Payrastre, B.; Nievers, M.; Boonstra, J.; Breton, M.; Verkleij, A. J.; Van Bergen en Henegouwen, P. M. P. A differential localization of phosphoinositide kinases, diacylglycerol kinase and phospholipase c in the nuclear matrix. J. Biol. Chem 1992, 267, 5078-5084.
10. Martelli, A. M.; Gilmour, R.S.; Bertagnolo, V.; Neri, L.M.; Manzoli, L.; Cocco, L. Nuclear localization and signalling activity of phosphoinositidase Cb in swiss 3t3 cells. Nature 1992, 358, 242-245.
11. Manzoli, F. A.; Capitani, S.; Maraldi, N. M.; Cocco, L.; Barnabei, O. Chromatin lipids and their possible role in gene expression. A study in normal and neoplastic cells. Adv Enzyme Regul 1978, 17, 175-194, doi:10.1016/0065-2571(79)90013-x.
12. Maraldi, N. M. M., G.; Cocco L.; Manzoli, F.A. Anatomical Waxwork Modeling: The History of the Bologna Anatomy Museum. The Anatomical Record 2000, 261, 5-10.
13. Follo, M. Y.; Finelli, C.; Clissa, C.; Mongiorgi, S.; Bosi, C.; Martinelli, G.; Baccarani, M.; Manzoli, L.; Martelli, A.M.; Cocco, L. Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia. J Clin Oncol 2009, 27, 782-790, doi:10.1200/JCO.2008.19.3748.
14. Follo, M.Y.; Finelli, C.; Mongiorgi, S.; Clissa, C.; Bosi, C.; Testoni, N.; Chiarini, F.; Ramazzotti, G.; Baccarani, M.; Martelli, A. M.; et al. Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. Proc Natl Acad Sci U S A 2009, 106, 16811-16816, doi:10.1073/pnas.0907109106.
15. Cocco, L.; Finelli, C.; Mongiorgi, S.; Clissa, C.; Russo, D.; Bosi, C.; Quaranta, M.; Malagola, M.; Parisi, S.; Stanzani, M.; et al. An increased expression of PI-PLCbeta1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes. J Leukoc Biol 2015, 98, 769-780, doi:10.1189/jlb.2MA1114-541R.
16. Ratti, S.; Marvi, M. V.; Mongiorgi, S.; Obeng, E. O.; Rusciano, I.; Ramazzotti, G.; Morandi, L.; Asioli, S.; Zoli, M.; Mazzatenta, D.; et al. Impact of phospholipase C beta1 in glioblastoma: a study on the main mechanisms of tumor aggressiveness. Cell Mol Life Sci 2022, 79, 195, doi:10.1007/s00018-022-04198-1.
17. Xian, J.; Owusu Obeng, E.; Ratti, S.; Rusciano, I.; Marvi, M. V.; Fazio, A.; De Stefano, A.; Mongiorgi, S.; Cappellini, A.; Ramazzotti, G.; et al. Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes. Cells 2020, 9, doi:10.3390/cells9030697.

The 2023 American Society for Microbiology Annual Meeting (ASM Microbe 2023) will be held in Houston, USA, from 15 to 19 June 2023. This annual meeting is the largest gathering of microbiologists in the world, and it is expected that nearly 8,000 professionals from all over the world will attend the meeting. Founded in 1899, the American Society for Microbiology (ASM) is the oldest and largest single life science society in the world, consisting of more than 50,000 scientists and health professionals, of which more than one-third of the members are from countries and regions outside the United States. The mission of the American Society for Microbiology is to promote and advance the science of microbiology.

Topics include:

• Disaster Microbiology;
• Emerging Infections – What is the next pandemic? (Focus on Nipah and Marburg);
• Natural Product Discovery and Synthesis;
• Combating the Climate Crisis with Critters: Microbial Carbon Capture;
• Powering the Future: Applied Microbiology in the Energy Industry;
• Equity and Access in Laboratory Diagnostics;
• Microbiome Management in a Changing World.

The following MDPI journals will be represented:

• Microorganisms;
• Journal of Fungi;
• Viruses;
• Applied Biosciences;
• MPs;
• IJMS;
• Vaccines;
• Fermentation;
• Diversity;
• Metabolites;
• Biomolecules;
• Antibiotics;
• Pathogens;
• Life.

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you at booth number #2504 in person and answering any questions you may have. For more information about the conference and our virtual booth, please visit the following link: https://asm.org/Events/ASM-Microbe/Home.

As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.

In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.

If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to newjournal-committee@mdpi.com.

MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page. 

We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.

On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.

The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.

As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.

MDPI's Preprints Platform – Preprints.org

To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.

During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.

We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.

For more information, please visit Preprints.org.

Conference: 11th National Conference on Bioinformatics and Systems Biology
Date: 25–27 February 2023
Place: Guangzhou, China

MDPI will be attending the 11th National Conference on Bioinformatics and Systems Biology (CCBSB2023) as the exhibitor. The National Academic Conference on Bioinformatics and Systems Biology has been successfully held for ten sessions since its first session in 1998. It is a national event with the highest academic level and the greatest influence in the field of bioinformatics research in China. The theme of the conference is "The Latest Frontier Research of Bioinformatics and Systems Biology and Their Applications", and the topics cover translational informatics and data sharing security, biomedical data mining and computing, genome informatics, artificial intelligence and life sciences, group bioinformatics and integrated biology, non-coding RNA and RNA informatics, network biology, major disease omics informatics, biological macromolecular structure prediction and simulation, bioinformatics algorithm research, biological data resources, bioinformatics and drugs discovery, computational synthetic biology, agricultural and forestry informatics and other bioinformatics, and other frontier directions.

The following MDPI journals will be represented:

• Genes;
• JPM;
• Cardiogenetics;
• Bioengineering;
• Biomolecules;
• Metabolites;
• Cells;
• Symmetry;
• Biomedicines;
• Computers;
• COVID;
• Epigenomes.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://ccbsb2022.casconf.cn/.

We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.

This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.

The mentee’s responsibilities include:

• Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
• Writing a brief promotion plan for the Special Issue;
• Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
• Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

• Conducting a final check before the Special Issue is published online;
• Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
• Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
• Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
• Making and submitting decisions regarding submissions with the assistance of mentees.

Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.

If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.

In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.

Conference: The 100th Anniversary Annual Meeting of The Physiological Society of Japan
Date: 14–16 March 2023
Venue: Kyoto International Conference Center *Hybrid Format, Kyoto, Japan

MDPI will be attending the 100th Anniversary Annual Meeting of The Physiological Society of Japan as the exhibitor. This meeting will take place from 14 to 16 March 2023 in Kyoto, Japan.

This meeting has been organized by the Physiological Society of Japan (PSJ), and will thus mark the 100th meeting of the society—the 100th Memorial meeting. This meeting has been given the theme of “Homeostasis for Sustainability—Toward the Next Century of Physiological Sciences”.

The following MDPI journals will be represented:

• Cells;
• IJMS;
• Biomolecules;
• Physiologia.

If you are planning to attend this conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person and answering any questions you may have.

For more information about the conference, please visit the following website: https://www2.aeplan.co.jp/psj2023/en_index/.

MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.

This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.

Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.

Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.

Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.

As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.

A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.

MDPI is proud to be the leading agent of the transition to open access.

"Thanks a Million" to all the contributors!

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.

The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).

The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.

Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.

Stanford University has recently published an update of the list of the top 2% most widely cited scientists—The World’s Top 2% Scientists.

The time node of the statistical data of this list is from 1960 to 2022, and it is divided into two lists: "Lifetime Scientific Influence Ranking" and "2022 Annual Scientific Influence Ranking". The "Lifetime Scientific Influence Ranking" counts the comprehensive influence performance of scientists during their careers, and the "2022 Annual Influence Ranking" focuses on highlighting the academic influence of scientists in the previous year. This ranking, considered the most prestigious worldwide, is based on the bibliometric information contained in the Scopus database and includes more than 200,000 researchers from the more than 10 million scientists considered to be active worldwide, with 22 scientific fields and 176 subfields taken into account.

We are pleased to share that 172 Editorial Board Members from MDPI’s Biomolecules (ISSN: 2218-273X) were featured in Stanford University’s list of the World’s Top 2% Scientists in 2022.

The latest Stanford rankings reflect the significant influence and research excellence of the scientists, who are committed to furthering their knowledge for the benefit of the world.

We would like to congratulate our Editorial Board Members on their excellent achievement and thank them for their immense contribution to the scientific progression and development of Biomolecules.

Conference: 2022 BMES Annual Meeting
Date: 12–15 October 2022
Place: San Antonio, Texas, USA
Booth: #346

MDPI will be attending the 2022 BMES Annual Meeting as an exhibitor from 12 to 15 October 2022 in San Antonio, Texas, USA.

BMES holds an annual meeting where they have hosted up to 5,500 biomedical engineers who attend more than 2,500 scientific presentations on cancer treatment, heart disease, women’s health, global health disparities, and more. The meeting allows members to advocate for their innovative solutions, demonstrating their commitment to the society’s core value of health equity for all individuals. In addition, BMES shares scientific information to inspire the up-and-coming generation through four scientific journals, three special interest groups, and collaborations with other scientific societies to elevate the visibility and significant impact that the biomedical engineering community has worldwide as the thought leaders behind the future of human health.

From 12 to 15 October 2022, in the vibrant multicultural city of San Antonio, we will celebrate the tremendous contributions made by BMES members in research, teaching, education, and the workforce that directly impact many sectors of our society. We also aim to highlight equity issues in healthcare and education, stemming from racial and socioeconomic diversity, gender and sexual orientation, and disabilities.

The following MDPI journals will be represented:

• Applied Sciences;
• Bioengineering;
• Biomedicines;
• Biomimetics;
• Biomolecules;
• Biosensors;
• Cancers;
• CIMB;
• Diseases.

Please do not hesitate to reach out if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.

To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.

We invite you to view the event recording:

During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:

• Peer Review Week 2022
• Research Integrity
• What We’ve Learned About Peer Review Reports
• 4 Steps to the Perfect Peer Review Report
• How to Write the Perfect Peer Review Report: An Interview
• Inviting Great Peer Reviewers

In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.

You can find the Podcast here.

We hope you enjoy the contents!

MDPI will be attending ASHG 2022, held in Los Angeles, USA, from 25 to 29 October 2022.

The following MDPI journals will be represented:

• Genes;
• JPM;
• Biomedicines;
• Biomolecules;
• Cardiogenetics;
• Cancers;
• Brain Science;
• Symmetry;
• Diagnostics;
• Metabolites;
• Cells;
• Biology;
• Humans;
• DNA.

If you plan on attending this conference, feel free to stop by our booth: #1844. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please see the following link:

https://www.ashg.org/meetings/2022-annual-meeting/.

MDPI will be attending SEBBM 2022, held in Malaga, Spain, from 6 to 9 September 2022.

The following MDPI journals will be represented:

• Genes (leading journal);
• Biomolecules (co-leading);
• Cells (co-leading);
• Marine Drugs;
• JFB;
• Biochem;
• CIMB;
• Metabolites;
• Proteomes;
• IJMS.

If you plan on attending this conference, feel free to stop by our booth #25. Our delegates look forward to meeting you in person to answer any questions you may have.

The 2021 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

For more information on Impact Factors and what it means to index academic journals, please visit our related blog posts.

* Journals given their first Impact Factor in 2022

Source: 2021 Journal Impact Factors, Journal Citation Reports ^TM (Clarivate, 2022)

The 2021 citation metrics have been officially released in Scopus!

We are pleased to announce that 182 MDPI journals are included, of which:

● 21 journals received their first CiteScore.
● 85% of journals increased their CiteScore from 2020.
● 155 journals (85%) ranked above average, in at least one category.

The following 65 MDPI journals (36%) ranked among the top 25% of journals, in at least one category:

Source: 2021 CiteScores™ (Elsevier)

In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize winners for the year 2021 in the “Biology & Life Sciences” category for their outstanding contributions among extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all the winners on their achievement.

MDPI will continue to provide support and recognition to the academic community.

Biology:

• Enrico Vito Perrino, CIHEAM, Mediterranean Agronomic Institute of Bari, Italy
• Dhirendra Kumar, National Institute of Environmental Health Sciences, Research Triangle Park, USA
• Carlos A. Viegas, Univesity of Trás-os-Montes e Alto Douro, Portugal
• Yuri Shavrukov, Flinders University, Australia
• Bipin Gaihre, Mayo Clinic, USA

Brain Sciences:

• Craig D. Workman, University of Iowa, USA
• Vivian Ciaramitaro, University of Massachusetts Boston, USA
• Yang Zhang, University of Minnesota, USA

Cells:

• Bonam Srinivasa Reddy, Université de Paris, France
• Homma Takujiro, Yamagata University, Japan
• Hwang, In Koo, Seoul National University, South Korea
• Kobeissy Firas, University of Florida, USA
• Rebelo, Sandra, University of Aveiro, Portugal

Diversity:

• Günter Gollmann, University of Vienna, Austria
• Stephan Koblmüller, University of Graz, Austria
• Emiliano Mori, Istituto di Ricerca sugli Ecosistemi Terrestri, Italy

Horticulturae:

• Joshua D. Klein, Agricultural Research Organization—The Volcani Center, Israel
• Ana Cristina S Figueiredo, Faculdade de Ciências da Universidade de Lisboa, Portugal

Insects:

• Carmelo Peter Bonsignore, Università Mediterranea di Reggio Calabria, Italy
• Klaus H. Hoffmann, University of Bayreuth, Germany
• Ivan Milosavljević, University of California, USA

Metabolites:

• Remigiusz Bachor, University of Wrocław, Poland
• Nguyen Phuoc Long, Inje University College of Medicine, South Korea
• Chi Chen, University of Minnesota, USA

Nutrients:

• Jadwiga Hamułka, Warsaw University of Life Sciences, Poland
• Grace Campbell, University of Sydney, Australia
• Nicholas Norwitz, Harvard Medical School, USA
• Stefan Kabisch, Charité University Hospital Berlin, Germany
• Luis Rodrigo, University of Oviedo, Spain

Veterinary Sciences:

• Carlos Viegas, Univesity of Trás-os-Montes e Alto Douro, Portugal
• Arvind Sharma, The University of Queensland, Australia

MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the 2021 winners in the “Biology & Life Sciences” category. The winners were selected by the journals’ editors.

We warmly congratulate the awarded young investigators for their outstanding contributions.

MDPI will continue to provide support and recognition to the academic community.

Agriculture:

• Carlos Guzmán, University of Cordoba, Spain

Animals:

• Katharina Hohlbaum, Freie Universität Berlin, Germany

Cells:

• Uri Ben-David, Tel Aviv University, Israel

Diversity:

• Enrico Lunghi, Institute of Zoology Chinese Academy of Sciences in Beijing, China

Foods:

• Guodong Zhang, University of Massachusetts Amherst, USA

Horticulturae:

• Luke Bell, Temperate Horticulture, University of Reading, UK

International Journal of Molecular Sciences:

• Alessandro D’Urso, University of Catania, Italy.
• Apostolos Zaravinos, University of Cyprus, Cyprus
• Cesar de la Fuente-Nunez, University of Pennsylvania, USA
• Maria Teresa Caccamo, Messina University, Italy
• Tiziana Bonifacino, University of Genoa, Italy

Journal of Fungi:

• Federico Baltar, University of Vienna, Austria
• Rebecca Drummond, University of Birmingham, UK
• Miriam Oses-Ruiz, Public University of Navarre, Spain

Life:

• João Pedro da Silva Machado Lobo, University of Porto, Portugal
• Vincenzo Russo, University of Campania Luigi Vanvitelli, Italy

Metabolites:

• Gabriele Rocchetti, Catholic University of Sacred Heart, Italy

Nutrients:

• Fiona Lavelle, Queen's University Belfast, UK
• Matthew Snelson, Monash University, Australia

Pathogens:

• Si Ming Man, Australian National University, Australia
• Jasper Fuk-Woo Chan, University of Hong Kong, China

Plants:

• Stefania Sut, University of Padova, Italy
• Mohamed Ahmed El-Esawi, Tanta University, Tanta, Egypt

Vaccines:

• Nicholas M. Provine, University of Oxford, UK

Viruses:

• Nicholas S. Heaton, Duke University, USA

We are proud to recognize the winners of MDPI’s 2021 Travel Awards in the “Biology & Life Sciences” category for their outstanding presentations and to present them with the prize.

MDPI journals regularly offer travel awards to encourage talented junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the winners of 2021 Travel Awards and wish them the greatest success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Agriculture:

• Zahra Bitarafan, Norwegian Institute of Bioeconomy Research (NIBIO), Norway
• Nikolaos Tsoulias, Leibniz Institute for Agricultural Engineering and Bioeconomy (ATB), Germany

Fermentation:

• Michela Verni, University of Bari, Italy
• Philipp Demling, RWTH Aachen University, Germany

Horticulturae:

• Jagveer Singh, Punjab Agricultural University, India
• Ibrar Hussain, State University of Londrina, Brazil

Microorganisms:

• Francis Muchaamba, University of Zurich, Switzerland

Methods and Protocols:

• Tanja Eisemann, SBP Medical Discovery Institute, USA

Nutrients:

• Mrinalini Dey, National Institute for Health Research, UK
• Ben Kirk, University of Melbourne, Australia
• Kirrilly Pursey, University of Newcastle, Australia
• Dieuwertje Kok, Wageningen University, the Netherlands
• Hanna Huber, University of Bonn, Germany
• Marlene Lages, University of Porto, Portugal
• Zohra S. Lassi, University of Adelaide, Australia
• Rik Olde Engberink, Amsterdam University Medicial Center, the Netherlands
• Sarah Warkentin, University of Porto (ISPUP), Portugal
• Álvaro Hernáez, Norwegian Institute of Public Health, Norway
• Leila Abdelhamid, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, USA
• Maria Michela Cesare, University of Siena, Italy
• Kaisa Hiippala, University of Helsinki, Finland

Pathogens:

• Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal
• Hejun Liu, Scripps Research Institute, USA
• Tomokazu Tamura, Princeton University, USA

Toxins:

• Cecilie Knudsen, Technical University of Denmark, Denmark
• Laura Biessy, Cawthron Institute, New Zealand
• Marcelo Mendes Rabelo, University of Florida, USA

Vaccines:

• Hee Chun Chung, Seoul National University, South Korea
• Alejandro Marin Lopez, Yale University, USA

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as the scientific merit, overall impact, and the quality of presentation of the papers published in the journal last year.

We are honored to present the winners in the subject areas of “Biology & Life Sciences”, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications.

MDPI will continue to provide support and recognition to the academic community.

Animals:

• “Effects of Dietary Betaine on Growth Performance, Digestive Function, Carcass Traitsand Meat Quality in Indigenous Yellow-Feathered Broilers under Long-Term Heat Stress”

by Wenchao Liu, Yilin Yuan, Chenyu Sun, Balamuralikrishnan Balasubramanian, Zhihui Zhao and Lilong An

Animals 2019, 9(8), 506, doi 10.3390/ani9080506

• “The Ethics of Human–Animal Relationships and Public Discourse: A Case Study of Lions Bred for Their Bones”

by Peter Coals, Dawn Burnham, Andrew Loveridge, David W. Macdonald, Michael ’t Sas-Rolfes, Vivienne L. Williams and John A. Vucetich

Animals 2019, 9(2), 52; doi 10.3390/ani9020052

• “The Potential Role of Insects as Feed: A Multi-Perspective Review”

by Giovanni Sogari, Mario Amato, Ilaria Biasato, Silvana Chiesa and Laura Gasco

Animals 2019, 9(4), 119; doi 10.3390/ani9040119

Antibodies:

• “Antibody Structure and Function: The Basis for Engineering Therapeutics”

by Mark L. Chiu; Dennis R. Goulet; Alexey Teplyakov and Gary L. Gilliland

Antibodies 2019, 8(4), 55; doi 10.3390/antib8040055

Antioxidants:

• “Antioxidant and Anti-Inflammatory Activities of Flavanones from Glycyrrhiza glabra L. (licorice) Leaf Phytocomplexes: Identification of Licoflavanone as a Modulator of NF-kB/MAPK Pathway”

by Luca Frattaruolo, Gabriele Carullo, Matteo Brindisi, Sarah Mazzotta, Luca Bellissimo, Vittoria Rago, Rosita Curcio, Vincenza Dolce, Francesca Aiello and Anna Rita Cappello

Antioxidants 2019, 8(6), 186; doi 10.3390/antiox8060186

• “LC-ESI-QTOF/MS Characterisation of Phenolic Acids and Flavonoids in Polyphenol-Rich Fruits and Vegetables and Their Potential Antioxidant Activities”

by Chunhe Gu, Kate Howell, Frank R. Dunshea and Hafiz A. R. Suleria

Antioxidants 2019, 8(9), 405; doi 10.3390/antiox8090405

• “Nutritional Value, Chemical Composition and Cytotoxic Properties of Common Purslane (Portulaca oleracea L.) in Relation to Harvesting Stage and Plant Part”

by Spyridon A. Petropoulos, Ângela Fernandes, Maria Inês Dias, Ioannis B. Vasilakoglou, Konstantinos Petrotos, Lillian Barros and Isabel C. F. R. Ferreira

Antioxidants 2019, 8(8), 293; doi 10.3390/antiox8080293

• “A Comprehensive Review on Lipid Oxidation in Meat and Meat Products”

by Rubén Domínguez, Mirian Pateiro, Mohammed Gagaoua, Francisco J. Barba, Wangang Zhang and José M. Lorenzo

Antioxidants 2019, 8(10), 429; doi 10.3390/antiox8100429

Biology:

• “The Mammalian Circadian Timing System and the Suprachiasmatic Nucleus as Its Pacemaker”

by Michael H. Hastings, Elizabeth S. Maywood and Marco Brancaccio

Biology 2019, 8(1), 13; doi 10.3390/biology8010013

• “Combined Effects of Acute Temperature Change and Elevated pCO₂ on the Metabolic Rates and Hypoxia Tolerances of Clearnose Skate (Rostaraja eglanteria), Summer Flounder (Paralichthys dentatus), and Thorny Skate (Amblyraja radiata)”

by Gail D. Schwieterman, Daniel P. Crear, Brooke N. Anderson, Danielle R. Lavoie, James A. Sulikowski, Peter G. Bushnell and Richard W. Brill

Biology 2019, 8(3), 56; doi 10.3390/biology8030056

Biomolecules:

• “Flagella-Driven Motility of Bacteria”

by Shuichi Nakamura and Tohru Minamino

Biomolecules 2019, 9(7), 279; doi 10.3390/biom9070279

• “Systematic FTIR Spectroscopy Study of the Secondary Structure Changes in Human Serum Albumin under Various Denaturation Conditions”

by Dmitrii Usoltsev, Vera Sitnikovaandrey Kajava and Mayya Uspenskaya

Biomolecules 2019, 9(8), 359; doi 10.3390/biom9080359

• “Quantification of Fecal Short Chain Fatty Acids by Liquid Chromatography Tandem Mass Spectrometry—Investigation of Pre-Analytic Stability”

by Gerhard Liebisch, Josef Ecker, Sebastian Roth, Sabine Schweizer, Veronika Öttl, Hans-Frieder Schött, Hongsup Yoon, Dirk Haller, Ernst Holler, Ralph Burkhardt and Silke Matysik

Biomolecules 2019, 9(4), 121; doi 10.3390/biom9040121

• “Cytotoxicity of Dendrimers”

by Anna Janaszewska, Joanna Lazniewska, Przemysław Trzepiński, Monika Marcinkowska and Barbara Klajnert-Maculewicz

Biomolecules 2019, 9(8), 330; doi 10.3390/biom9080330

Cells:

• “Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models”

by Heng Sheng Sow, Jiang Ren, Marcel Camps, Ferry Ossendorp and Peter ten Dijke

Cells 2019, 8(4), 320; doi 10.3390/cells8040320

• “Exosome Treatment Enhances Anti-Inflammatory M2 Macrophages and Reduces Inflammation-Induced Pyroptosis in Doxorubicin-Induced Cardiomyopathy”

by Dinender K. Singla, Taylor A. Johnson and Zahra Tavakoli Dargani

Cells 2019, 8(10), 1224; doi 10.3390/cells8101224

• “Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis”

by Laura M. Doyle and Michael Zhuo Wang

Cells 2019, 8(7), 727; doi 10.3390/cells8070727

• “Mesenchymal Stem Cells for Regenerative Medicine”

by Yu Han, Xuezhou Li, Yanbo Zhang, Yuping Han, Fei Chang and Jianxun Ding

Cells 2019, 8(8), 886; doi 10.3390/cells8080886

Genes:

• “A High-Quality De novo Genome Assembly from a Single Mosquito Using PacBio Sequencing”

by Sarah B. Kingan, Haynes Heaton, Juliana Cudini, Christine C. Lambert, Primo Baybayan, Brendan D. Galvin, Richard Durbin, Jonas Korlach and Mara K. N. Lawniczak

Genes 2019, 10(1), 62; doi 10.3390/genes10010062

• “Eukaryotic 5-methylcytosine (m⁵C) RNA Methyltransferases: Mechanisms, Cellular Functions, and Links to Disease”

by Katherine E Bohnsack, Claudia Höbartner and Markus T Bohnsack

Genes 2019, 10(2), 102; doi 10.3390/genes10020102

• “Tree Lab: Portable Genomics for Early Detection of Plant Viruses and Pests in Sub-Saharan Africa”

by Laura M. Boykin, Peter Sseruwagi, Titus Alicai, Elijah Ateka, Ibrahim Umar Mohammed, Jo-Ann L. Stanton, Charles Kayuki, Deogratius Mark, Tarcisius Fute, Joel Erasto, Hilda Bachwenkizi, Brenda Muga, Naomi Mumo, Jenniffer Mwangi, Phillip Abidrabo, Geoffrey Okao-Okuja, Geresemu Omuut, Jacinta Akol, Hellen B. Apio, Francis Osingada, Monica A. Kehoe, David Eccles, Anders Savill, Stephen Lamb, Tonny Kinene, Christopher B. Rawle, Abishek Muralidhar, Kirsty Mayall, Fred Tairo and Joseph Ndunguru

Genes 2019, 10(9), 632; doi 10.3390/genes10090632

• “Transcription Factors Associated with Abiotic and Biotic Stress Tolerance and Their Potential for Crops Improvement”

by Elamin Hafiz Baillo, Roy Njoroge Kimotho, Zhengbin Zhang and Ping Xu

Genes 2019, 10(10), 771; doi 10.3390/genes10100771

Horticulturae:

• “Recent Advances in Hormonal Regulation and Cross-Talk during Non-Climacteric Fruit Development and Ripening”

by Lida Fuentes, Carlos R. Figueroa and Monika Valdenegro

Horticulturae 2019, 5(2), 45; doi 10.3390/horticulturae5020045

• “Evaluation of Two Wild Populations of Hedge Mustard (Sisymbrium officinale (L.) Scop.) as a Potential Leafy Vegetable”

by Marta Guarise, Gigliola Borgonovo, Angela Bassoli and Antonio Ferrante

Horticulturae 2019, 5(1), 13; doi 10.3390/horticulturae5010013

Insects:

• “Olfactory Preference of Drosophila suzukii Shifts between Fruit and Fermentation Cues over the Season: Effects of Physiological Status”

by Rik Clymans, Vincent Van Kerckvoorde, Eva Bangels, Wannes Akkermans, Ammar Alhmedi, Patrick De Clercq, Tim Beliën and Dany bylemans

Insects 2019, 10(7), 200; doi 10.3390/insects10070200

• “Telenomus remus, a Candidate Parasitoid for the Biological Control of Spodoptera frugiperda in Africa, is already Present on the Continent”

by Marc Kenis, Hannalene du Plessis, Johnnie Van den Berg, Malick Niango Ba, Georg Goergen, Koffi Eric Kwadjo, Ibrahim Baoua, Tadele Tefera, Alan Buddie, Giovanni Cafà, Lisa Offord, Ivan Rwomushana and Andrew Polaszek

Insects 2019, 10(4), 92; doi 10.3390/insects10040092

• “Symbiotic Plant Biomass Decomposition in Fungus-Growing Termites”

by Rafael R. da Costa, Haofu Hu, Hongjie Li and Michael Poulsen

Insects 2019, 10(4), 87; doi 10.3390/insects10040087

International Journal of Molecular Sciences:

• “Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks”

by Rüdiger Hardeland

Int. J. Mol. Sci. 2019, 20(5), 1223; doi 10.3390/ijms20051223

• “Causative Links between Protein Aggregation and Oxidative Stress: A Review”

by Elise Lévy, Nadine El Banna, Dorothée Baïlle, Amélie Heneman-Masurel, Sandrine Truchet, Human Rezaei, Meng-Er Huang, Vincent Béringue, Davy Martin and Laurence Vernis

Int. J. Mol. Sci. 2019, 20(16), 3896; doi 10.3390/ijms20163896

• “Immunobiology of Atherosclerosis: A Complex Net of Interactions”

by Beatriz Herrero-Fernandez, Raquel Gomez-Bris, Beatriz Somovilla-Crespo and Jose Maria Gonzalez-Granado

Int. J. Mol. Sci. 2019, 20(21), 5293; doi 10.3390/ijms20215293

• “Development of a Gut-on-a-Chip Model for High Throughput Disease Modeling and Drug Discovery”

by Claudia Beaurivage, Elena Naumovska, Yee Xiang Chang, Edo D. Elstak, Arnaud Nicolas, Heidi Wouters, Guido van Moolenbroek, Henriëtte L. Lanz, Sebastiaan J. Trietsch, Jos Joore, Paul Vulto, Richard A.J. Janssen, Kai S. Erdmann, Jan Stallen and Dorota Kurek

Int. J. Mol. Sci. 2019, 20(22), 5661; doi 10.3390/ijms20225661

• “Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammationand Angiogenesis”

by Maiko Okano, Masanori Oshi, Ali Linsk Butash, Eriko Katsuta, Kazunoshin Tachibana, Katsuharu Saito, Hirokazu Okayama, Xuan Peng, Li Yan, Koji Kono, Toru Ohtake and Kazuaki Takabe

Int. J. Mol. Sci. 2019, 20(17), 4197; doi 10.3390/ijms20174197

• “CGRP Induces Differential Regulation of Cytokines from Satellite Glial Cells in Trigeminal Ganglia and Orofacial Nociception”

by Shaista Afroz, Rieko Arakaki, Takuma Iwasa, Masamitsu Oshima, Maki Hosoki, Miho Inoue, Otto Baba, Yoshihiro Okayama and Yoshizo Matsuka

Int. J. Mol. Sci. 2019, 20(3), 711; doi 10.3390/ijms20030711

Life:

• “Characterization of Resistance in Gram-Negative Urinary Isolates Using Existing and Novel Indicators of Clinical Relevance: A 10-Year Data Analysis”

by Márió Gajdács, Zoltán Bátori, Marianna Ábrók, Andrea Lázár and Katalin Burián

Life 2020, 10(2), 16; doi 10.3390/life10020016

• “Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease”

by Carla Ferreira, Catarina Almeida, Sandra Tenreiro and Alexandre Quintas

Life 2020, 10(6), 86; doi 10.3390/life10060086

Nutrients:

• “Gut Microbiome: Profound Implications for Diet and Disease”

by Ronald D. Hills, Benjamin A. Pontefract, Hillary R. Mishcon, Cody A. Black, Steven C. Sutton and Cory R. Theberge

Nutrients 2019, 11(7), 1613; doi 10.3390/nu11071613

• “Vitamin C Can Shorten the Length of Stay in the ICU: A Meta-Analysis”

by Harri Hemilä and Elizabeth Chalker

Nutrients 2019, 11(4), 708; doi 10.3390/nu11040708

• “Early Time-Restricted Feeding Improves 24-Hour Glucose Levels and Affects Markers of the Circadian Clock, Aging, and Autophagy in Humans”

by Humaira Jamshed, Robbie A. Beyl, Deborah L. Della Manna, Eddy S. Yang, Eric Ravussin and Courtney M. Peterson

Nutrients 2019, 11(6), 1234; doi 10.3390/nu11061234

Pathogens:

• “Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome”

by Israr Kha, Naeem Ullah, Lajia Zha, Yanrui Bai, Ashiq Khan, Tang Zhao, Tuanjie Che and Chunjiang Zhang

Pathogens 2019, 8(3), 126; doi 10.3390/pathogens8030126

• “Candida albicans Interactions with Mucosal Surfaces during Health and Disease”

by Spyridoula-Angeliki Nikou,Nessim Kichik, Rhys Brown, Nicole O. Ponde, Jemima Ho, Julian R. Naglik and Jonathan P. Richardson

Pathogens 2019, 8(2), 53; doi 10.3390/pathogens8020053

• “Bacteriophages in Natural and Artificial Environments”

by Steven Batinovic, Flavia Wassef, Sarah A. Knowler, Daniel T.F. Rice, Cassandra R. Stanton, Jayson Rose, Joseph Tucci, Tadashi Nittami, Antony Vinh, Grant R. Drummond, Christopher G. Sobey, Hiu Tat Chan, Robert J. Seviour, Steve Petrovski and Ashley E. Franks

Pathogens 2019, 8(3), 100; doi 10.3390/pathogens8030100

Plants:

• “Plant Disease Detection and Classification by Deep Learning”

by Muhammad Hammad Saleem, Johan Potgieter and Khalid Mahmood Arif 

Plants 2019, 8(11), 468; doi 10.3390/plants8110468

• “Involvement of Phenolic Acids in Short-Term Adaptation to Salinity Stress is Species-Specific among Brassicaceae”

by Ida Linić, Dunja Šamec, Jiří Grúz, Valerija Vujčić Bok, Miroslav Strnad and Branka Salopek-Sondi

Plants 2019, 8(6), 155; doi 10.3390/plants8060155

• “Isoform-Specific NO Synthesis by Arabidopsis thaliana Nitrate Reductase”

by Marie Agatha Mohn, Besarta Thaqi and Katrin Fischer-Schrader

Plants 2019, 8(3), 67; doi 10.3390/plants8030067

• “GWAS for Starch-Related Parameters in Japonica Rice (Oryza sativa L.)”

by Chiara Biselliandrea Volante, Francesca Desiderio, Alessandro Tondelli, Alberto Gianinetti, Franca Finocchiaro, Federica Taddei, Laura Gazza, Daniela Sgrulletta, Luigi Cattivelli and Giampiero Valè

Plants 2019, 8(8), 292; doi 10.3390/plants8080292

We are pleased to announce the launch of a new initiative, the Special Issue Mentor Program. 

This program intends to provide an opportunity for early-career scientists to enhance their editing, networking, and organizational skills and to work closely with our journal to gain more editorial experience. Early-career scientists who have novel ideas for new Special Issues of Biomolecules (5-Year IF: 5.362, ISSN 2218-273X) will act as Guest Editors under the mentorship of an experienced scientist; this mentor could be a member of the Biomolecules Editorial Board or may be from other well-established research institutes or laboratories, etc. 

If you are interested in this opportunity, please send your Special Issue proposal to the Biomolecules Editorial Office (biomolecules@mdpi.com); we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. When the Special Issue is closed, our office will provide certificates to all of our mentors and to those who complete the program. Younger scholars will be prioritized as candidates for our journal award. 

In addition to the new Special Issue Mentor Program, Biomolecules will continue to welcome all Special Issue proposals based on hot research topics in the field as usual.

We are pleased to announce that Prof. Dr. Robert V. (Rob) Stahelin has been appointed Editor-in-Chief of the Section “Biomacromolecules: Lipids” in Biomolecules (ISSN 2218-273X). 

Prof. Dr. Robert V. Stahelin is the Retter Professor of Pharmacy and a Professor of Medicinal Chemistry and Molecular Pharmacology at Purdue University, West Lafayette, IN, USA. Since receiving his Ph.D. in Chemistry, in 2003, from at the University of Illinois in Chicago in 2003, he has specialized in biological membranes, sphingolipids signaling in cancers, and lipid-binding proteins. His current research is targeted at understanding how viral proteins interact with host cell lipids to hijack host cell membranes for the formation of the viral lipid envelope. The goals of his current research are to identify protein drug targets in the viral life cycle, understanding the structural and biophysical basis of viral assembly and budding, and understanding their biological mechanisms by which viruses alter host lipid metabolism. He has published more than 120 PubMed/SCIE-listed papers on lipids. 

The following is a short Q&A with Prof. Dr. Robert V. Stahelin, who shared his vision for the journal with us, as well as his views on the research area and open access publishing: 

1. What appealed to you about the journal that made you want to take the role as its Section Editor-in-Chief?

I have had the pleasure of reviewing articles for Biomolecules, as well as publishing three articles in the journal in recent years. I was excited for the opportunity to help improve the quality of submissions to the lipids section of this journal and ensure that cutting-edge lipid topics are sought after for future submissions. 

2. What motivated you to go into the field of lipids?

When I was an undergraduate researcher, I worked on a bacterial protein that could be inserted into lipid membranes. This was fascinating to me, and the more I learned about lipid membranes and how proteins are associated with lipid headgroups, the more enthusiastic I was about digging deeper into this field. My graduate work with Dr. Wonhwa Cho focused on the basis of lipid-protein interactions and I have been immersed in this field ever since. 

3. What does the future of this field of research look like?

The lipid research field continues to grow and expand into new areas. I expect to see more studies encompassing lipids in precision medicine, cancer biology, host-pathogen interactions, and lipid biophysical properties involved in cell signaling and the molecular basis of disease.  

4. Who will be your main readers? Who should contribute to the journal, and what can readers expect?

Our main readers will be those interested in the biochemical and biophysical properties of lipid molecules and how lipids are involved in health and disease. Readers can expect to find articles that have undergone rigorous peer review and those that present cutting-edge findings in a variety of fields related to lipids. Authors whose work encompasses important and high-quality findings on lipids from diverse scientific backgrounds should consider submitting their work. 

5. What do you think about the development of open access in the publishing field? How do you respond to open access skeptics?

I support open access and making articles accessible to anyone, as opposed to restricting access behind a paywall. One concern of open access, however, is that it usually costs the submitting author higher fees of publication. However, there are often alternative means to assist authors who may not be able to afford the publication cost of open access. 

We extend a warm welcome to Prof. Dr. Robert V. Stahelin as he starts his new role as the Section Editor-in-Chief, and we look forward to him leading Biomolecules to achieve many more milestones. 

Biomolecules Editorial Office

It is our great honor to congratulate the Editorial Board Members and Editors in MDPI's journals who have been distinguished as 2021 Highly Cited Researchers by Clarivate, according to Web of Science data. We herewith express our gratitude for the immense impact the named researchers continue to make on scientific progress and on our journals' development.

Clarivate's annual list of Highly Cited Researchers^TM identifies the most highly cited scientists for the past decade. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 22 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

The full list of 2021 Highly Cited Researchers  can be accessed at the following webpage in the Web of Science^TM https://recognition.webofscience.com/awards/highly-cited/2021/.

--- Highly Cited Researchers (HCR) is a Clarivate product.

Academic editors play a crucial role in leading our journals and ensuring that each article undergoes a robust and timely peer-review. With the launch of Topics this year and addition of Topic Editors to our family of academic editors, we decided it would be a good time to restructure our academic boards, thus providing more clarity and support for each role. MDPI is pleased to announce the launch of a new position—Topical Advisory Panel Member, that will replace the previous position of Topics Board Member. The Topical Advisory Panel will be comprised of early career researchers eager to gain experience in editorial work.

The main responsibility of the new members of the Topical Advisory Panel is to regularly provide support to Guest Editors, Topic Editors, and Section Board Members. The responsibilities of the Topical Advisory Panel are available here: https://www.mdpi.com/editors.

Each year, the members’ performances are evaluated, and outstanding members are promoted to the Editorial Board by the Editor-in-Chief.

To qualify as a Topical Advisory Panel Member, applicants must:

• Have expertise and experience in the field related to the journal;
• Have received a Ph.D. in the last 10 years, approximately;
• Have at least 6-8 published papers in the last 5 years as first author or corresponding author;
• Currently hold an independent research position in academia or a government institute.

If you are interested in this role, please contact the editorial office by email.

We look forward to hearing from you soon.

To expand our biomolecules science community, Biomolecules is launching a new position—Topical Advisory Panel Member.

Biomolecules (ISSN 2218-273X) is an international, peer-reviewed open access journal whose scope lays at the intersection between chemistry, biology, molecular medicine and material sciences. The journal has a strong focus on structures and functions of bioactive and biogenic substances, molecular mechanisms with biological and medical implications as well as biomaterials and their applications. Biomolecules publishes articles, reviews, communications and editorials. The 2020 impact factor for Biomolecules was 4.879. The Biomolecules website can be accessed here: https://www.mdpi.com/journal/biomolecules.

Should you decide to serve on the Topical Advisory Panel, you would be responsible for some of the following tasks, depending on your availability:

• Providing regular reviews of manuscripts;
• Setting up at least one Special Issue (SI) in partnership with a senior researcher within two years of the appointment and proposing a detailed strategic plan for the SI. The topic of the proposal should be within the scope of the journal. The scope of the Special Issue should be broad enough to attract a reasonable number of submissions but narrow enough to provide a cohesive collection of articles. The Special Issue should cover a small part of the scope of the journal, but not its entirety;
• Providing a detailed strategic plan for the SI including assisting in preparing the Special Issue’s/Topic’s title, aim and scope, summary and keywords, soliciting papers and promoting the SI;
• Providing support for the Special Issues/Topics related to your expertise when the Guest Editor(s) is not available. This includes SI promotion via social media and giving advice on some scientific cases;
• Promoting the journal at conferences (adding 1–2 slides into your presentation, distributing flyers, recommending the journal to your colleagues, etc.), on social media and other relevant platforms;
• Participating in working with Editorial Board Members or the Editorial Office in promoting high-quality/featured papers (for example writing summary or highlights for the editor's selected papers).

If you are interested in this position or know of potential candidates to recommend, or wish to request further information, please contact the Biomolecules Editorial Office (biomolecules@mdpi.com). We look forward to hearing from you soon.

Founded in 1996, MDPI was one of the first fully Open Access publisher. Over 25 years MDPI has grown to become the largest Open Access publisher globally, publishing over 160,000 articles across more than 350 journals in 2020. At the core, MDPI was founded in response to a pressing need of fast publication and inclusion. The scholar was set at the centre of the publication process for the first time. Acting as a service provider, rather than a product provider, MDPI exists to help scientists achive their objective to disseminate research results. At MDPI, we believe scientists deserve a better service from the publishing world.

The International Open Access Week (Open Access Week), founded by the SPARC (the Scholarly Publishing and Academic Resources Coalition) Alliance and student partners in 2008, has been successfully running for 13 years. As an advocate and pioneer of open access publishing, MDPI actively responds to the call of International Open Access Week. This year’s theme of “It Matters How We Open Knowledge: Building Structural Equity” highlights the Recommendation’s call for equitable participation from all authors and readers.

For the last 25 years, MDPI has been committed to disseminating open research. Here is a video showing MDPI’s Commitment to Equity, Inclusion and Diversity for More than 25 Years.

International Open Access Week is an important opportunity to catalyze new conversations, create connections across and between communities that can facilitate this co-design, and advance progress in the building of more equitable foundations for opening knowledge—discussions and actions that need to be continued, year in and year out. MDPI has always aimed to provide professional and efficient publishing services to scholars around the world.

Our mission is to make scientific research accessible to everyone; this year, we interview and hold discussions with open science ambassadors on how to build an equal and inclusive environment for open science. Academic editors help us collaborate with more institutions to advocate for open access ideas.

Read our anniversary blog post: "Sharing 'Collective Human Knowledge': The Benefits of Open Access Publication"

Besides this, our scientific community is a key driver of our success and MDPI’s remarkable growth. Despite the pandemic, we have prepared online conferences and workshops to gather scholars from different communities.

The Basel Sustainable Publishing online forum provides an equal opportunity for stakeholders and researchers from multi-cultural environments to exchange ideas and eliminate barriers to participation.

Conference date: 25 October 2021, online
Conference website: https://bspf2021.sciforum.net/
Main topics: MDPI discusses the current dilemma of open access science from various perspectives such as governments, libraries, and publishers, and related measures on how to change the status quo of discrimination from a global perspective.

We aim to support equality, inclusion, diversity, and accessibility in scholarly communications. We collaborate with universities and key laboratories and have scholarly communications with researchers, teachers, and students on open access workshops.

• 25 October 2021
  Energies journal and Institute of Mechanics, Chinese Academy of Sciences

• 28 October 2021
  Machines journal and State Key Laboratory of Traction Power, Southwest Jiaotong University

• 29 October 2021
  Processes journal and Beijing Institute of Technology

• 29 October 2021
  Coatings journal and Wuhan University of Technology

MDPI is committed to providing open access and high-quality publishing services for scholars and promoting rapid dissemination of academic achievements. We hope to promote the practices and policies of open access publishing and diversify the dissemination of academic achievements.

We are pleased to announce that Prof. Dr. Jürg Bähler has been appointed Editor-in-Chief of the “Molecular Genetics” Section in Biomolecules (ISSN 2218-273X).

Name: Prof. Dr. Jürg Bähler

Affiliation: Department of Genetics, Evolution & Environment and Institute of Healthy Ageing, University College London, Darwin Building, Gower Street, London, WC1E 6BT, UK

Interests: gene regulation; genomics; transcriptomics; non-coding RNAs; genome function and evolution; fission yeast; cellular quiescence and aging

The following is a short Q&A with Prof. Dr. Jürg Bähler:

1. What appealed to you about the journal that made you want to take the role as its Section Editor-in-Chief?
   Biomolecules make rapid decisions on submitted manuscripts without compromising on scrutiny and peer-review quality.
2. What is your vision for the journal?
   To further increase the quality, rather than quantity, of published papers in a broad range of topics.
3. What does the future of this field of research look like?
   The advances in genome editing, like CRISPR/Cas9, are now enabling molecular genetic approaches in many different organisms, beyond the traditional model organisms. Other technological advances are allowing more and more types of large-scale or single-cell analyses. These developments will provide many fresh insights into gene function, genetic diversity, and molecular processes contributing to phenotypes.
4. What do you think of the development of Open Access in the publishing field?
   It makes no sense to restrict access to scientific publications behind paywalls, and Open Access publishing is a positive development to maximize scientific progress.

We extend a warm welcome to Prof. Dr. Jürg Bähler as he starts his new role as the Section Editor-in-Chief, and we look forward to him leading Biomolecules to achieve many more milestones.

Biomolecules Editorial Office

Rigorous peer-review is the cornerstone of high-quality academic publishing. Over 369,916 scholars served as reviewers for MDPI journals in 2020. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list of all reviewers’ names to express our gratitude. In addition, this year, the MDPI Top Reviewer Award was announced, to recognize the very best reviewers for their expertise and dedication, and their high-quality, and timely review reports. We are pleased to announce the following winners of the 2020 MDPI Top Reviewer Award:

• Adriana Burlea-Schiopoiu;
• Alban Kuriqi;
• Álvaro González-Vila;
• Alessandro Alaimo;
• Alexey Beskopylny;
• Alexander Yu Churyumov;
• Alberto Fernández-Isabel;
• Andrea Mastinu;
• Antonios N. Papadopoulos;
• Anton Rassõlkin;
• Antonio Humberto Hamad Minervino;
• Arkadiusz Matwijczuk;
• Artur Słomka;
• Baojie He;
• Bartłomiej Potaniec;
• Bojan Đurin;
• Camilo Arturo Rodriguez Diaz;
• Carmelo Maria Musarella;
• Chiachung Chen;
• Chiman Kwan;
• Cristian Busu;
• Danil Pimenov;
• Dan-Cristian Dabija;
• Delfín Ortega-Sánchez;
• Demetrio Antonio Zema;
• Denis Butusov;
• Elena Lucchi;
• Gaurab Dutta;
• Livia Anastasiu;
• M. R. Safaei.

For more information about how to become a reviewer of MDPI journals, please see: www.mdpi.com/reviewers.

UN's 17 Sustainable Development Goals (SDGs) are the blueprint to achieve a better and more sustainable future for all. In 2020 the SDG Publishers Compact was launched, aimed to inspire publishers and accelerate progress to achieve the 17 goals by 2030. Members of the programme are committed to support the publication of materials that will promote and inspire actions towards SDGs.

MDPI is an eager advocate of SDGs and has already been supporting the programme by creating Special Issues and publishing a series of books on SDGs prior to joining the Compact in 2021. MDPI's Sustainability Foundation initiated the World Sustainability Awards in 2016. We fully support UN's goals to promote sustainable actions that make the world a better place for all and, as part of its commitment, we will focus our actions on SDG10: Reduced Inequalities whilst promoting all 17 SDGs. For more details, please visit the programme’s website: https://www.un.org/sustainabledevelopment/sdg-publishers-compact/.

Joining this initiative was a unanimous decision. MDPI has in its core values the dissemination of science for all, breaking the wall between research access and under-represented members of the scientific community and the general population. To support this initiative further and continue to support under-represented scientists, MDPI will take a series of actions that will be announced once ready.

The first action MDPI takes is to nominate Dr. Liliane Auwerter as the coordinator of the programme. Dr. Auwerter studied Environmental Process Technology (UTFPR, Brazil), obtained her MSc degree in Water and Environmental Engineering (University of Surrey, UK) and in 2020 completed her PhD in self-healing low-friction materials for water transport (Imperial College London, UK), always focusing on diverse scientific projects that would potentially bring sustainability to industrial processes. As a student in Brazil, she engaged in volunteering activities focused on environmental education and took part in the Millennial Development Goals meetings held at the university.

For more information, please contact:
Dr. Liliane Auwerter
Scientific Officer
liliane.auwerter@mdpi.com

This serves to announce to our valued authors based in Japan that value-added tax, or consumption tax will now be imposed on article processing fees and other service fees for all papers submitted, or resubmitted (assigned new paper IDs), effective from 15 August 2021. The change is in accordance with the Japanese "Act for Partial Revision of the Income Tax Act and Other Acts" (Act No. 9 of 2015), which includes a revision of consumption taxation on cross-border supplies of services such as digital content distribution.

For additional information from the National Tax Agency please see here ("Cross-border supplies of electronic services").

Contact: Setsuko Nishihara, MDPI Tokyo

In order to specifically develop different research areas and attract more high-quality papers, we are pleased to announce the addition of the following three new sections in Biomolecules to cover all the disciplines of natural and applied science:

• Molecular Biomarkers
• Molecular Reproduction
• Molecular Biophysics

Alternatively, you may wish to submit your work directly via the following link: https://susy.mdpi.com/user/manuscripts/upload?form[journal_id]=111.

Biomolecules is a peer-reviewed, open access journal on structures and functions of bioactive and biogenic substances, molecular mechanisms with biological and medical implications, as well as biomaterials and their applications. Biomolecules is published monthly online by MDPI.

The 2020 citation metrics have been officially released in the Journal Citation Reports (JCR)!

We are pleased to announce that 85 MDPI journals are included, of which:

• 10 journals received their first impact factor
• 96% of journals increased their impact factor from 2019
• 32 journals (38%) ranked among the top 25% of journals, in at least one category

* Journals given their first Impact Factor in 2021

Source: 2020 Journal Impact Factors, Journal Citation Reports ® (Clarivate, 2021)